deltatrials
Completed OBSERVATIONAL NCT06405308

Robotic Natural Orifice Specimen Extraction Surgery Versus Robotic Transabdominal Specimen Extraction Surgery for Early-Stage Rectal Cancer

Robotic Natural Orifice Specimen Extraction Surgery Versus Robotic Transabdominal Specimen Extraction Surgery for Rectal Cancer: a Multicentre Propensity Score-Matched Analysis

Sponsor: Taiyuan Li

Conditions Natural Orifice Specimen Extraction Surgery Rectal Cancer Robotic Surgery
Interventions R-NOSES group R-TSES group
Updated 3 times since 2024 Last updated: May 9, 2024 Started: Oct 1, 2023 Primary completion: Jan 15, 2024 Completion: Jan 15, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06405308, this observational or N/A phase trial focuses on Natural Orifice Specimen Extraction Surgery and Rectal Cancer and remains completed. Sponsored by Taiyuan Li, it has been updated 3 times since 2023, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

3 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jun 2024 — Jul 2024 [monthly]

    Completed

    First recorded

Oct 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Taiyuan Li
Data source: The First Affiliated Hospital of Nanchang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations